LungLife AI, Inc (DI) (Reg S, Cat 3) (LLA)

 15.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 30.00
  • 52 Week Low: 15.00
  • Currency: UK Pounds
  • Shares Issued: 5.17m
  • Volume: 0
  • Market Cap: £0.78m

LLA Overview

LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence ("AI"). Lung cancer is one of the most lethal cancers, accounting for nearly a quarter of all cancer-related deaths in the US, and its global incidence has increased by 37 per cent. from 2007-2017. The Company's diagnostic solutions are designed to make significant improvements in the early detection of lung cancer.

Key Personnel

CEO: Paul Carmelo Pagano
Chief Finance Officer: David Mark Anderson
Non-Executive Chairman: Gordon Roy Davis
Senior Independent Non-Executive Director: Andrew Norman Boteler
Non-Executive Dir: Sara Barrington

Contact Details

Address: 850 New Burton Road, Suite 201, Dover, Delaware, USA, 19904
Website: https://www.lunglifeai.com/

Listings

Index: FTSE AIM All-Share
Domestic Listings: LSE:LLAI
ISIN: USU5500L1128

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

LLA Market Data

Currency UK Pounds
Share Price 15.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 30.00
52 Week Low 15.00
Volume 0
Shares Issued 5.17m
Market Cap £0.78m

LLA Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

LLA Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

LLA Key Personnel

CEO Paul Carmelo Pagano

Top of Page